Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil works better than nitroglycerin for treating impotence with fewer side effects.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.

Occipital donor sites for skin grafts heal faster, hurt less, look better, and have fewer complications than femoral sites.

Doctors need to understand statistics to properly evaluate clinical trials for patient care.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

Cimetidine did not reduce hair growth in women with hirsutism.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Physical activity, height, and smoking affect prostate cancer risk.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

Minoxidil solution safely and effectively treats hair loss.

Male pattern baldness may predict prostate cancer risk.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Implant safely and effectively treats hair loss.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.